Displaying 41 - 50 of 516
AACE Members:
The Annual Business Meeting of the AACE membership will be held via a ZOOM Virtual Conference Call on Friday, September 11, 2020, from 4:00 pm – 5:00 pm, Eastern Standard Time. In order to participate in the meeting, advance registration was required. Registration is now closed.
Those that registered should be on the lookout for more information via email.
The purpose of the meeting will be to conduct business of the Association, including:
- Proposed Amendments to the AACE Bylaws
- Announcement of Results of the 2020 AACE…
more
AACE members: Please watch the accompanying video as Drs. Leslie Eldeiry, Scott Isaacs, and Matthew Levine provide an important AACE member update on behalf of the Board of Directors on two upcoming changes regarding our brand and community. These will be further discussed at the Annual Business Meeting on September 11, 2020, and you can find more information on registering for this meeting
here.
Below is the transcript of the video message:…
more
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1598370513374-0'); });
Read more about thyroid eye disease, including recent research and case studies from
Endocrine Practice and
AACE Clinical Case Reports.
Study: Assessing the Management of Thyroid Eye Disease-Related Strabismus
Thyroid eye disease (TED)-related strabismus warrants careful evaluation and management and comprises several surgical and non-surgical options to achieve an optimal outcome, according to a review published in the …
moreAWARD-11 showed 3.0 mg and 4.5 mg doses led to additional blood sugar control; as a secondary endpoint, both doses also led to weight loss
The U.S. Food and Drug Administration (FDA) approved two additional doses of Eli Lilly and Company's (NYSE: LLY) Trulicity® (dulaglutide). The approval expands the label of once-weekly Trulicity to include 3.0 mg and 4.5 mg doses based on data from AWARD-11. The phase 3 trial showed the additional doses led to further benefits in A1C and body weight reduction when compared to Trulicity 1.5 mg in people with type 2 diabetes.
"The…
moreAACE is fortunate to have talented, dedicated individuals to serve on its Board of Directors. We are thankful for the contributions of AACE Past Presidents.
Susan L. Samson, MD, PhD, FRCPC, FACE (2024)
S. Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE (2022-2023)
Felice A. Caldarella, MD, MBA, FACP, CDCES, FACE(2021-2022)
Howard M. Lando, MD, FACP, FACE(2020-2021)
Sandra L. Weber, MD, FACP, MACE(2019-2020)
Daniel L. Hurley, MD, MACE (2018-2019)
Jonathan D. Leffert, MD, FACP, FACE, ECNU (2017-2018)
Pauline M. Camacho, MD, FACE(2016-2017)
George Grunberger, MD…
moreJoin us on October 20, 2020 as we launch a new AACE.
AACE is a dynamic organization that is leading the way in the endocrine community with clinical knowledge and experience.
- We are proud of AACE’s leadership role elevating clinical endocrinology.
- We need to evolve and adapt to what is happening in our world related to changing demographics, clinical practice developments, shifting health priorities, and financial considerations for medical associations.
- To meet our members’ needs, we are committed to building an…
more
These dynamic leaders of the endocrine field served as presidents of the American College of Endocrinology. ACE is grateful for their service to the organization!
Susan L. Samson, MD, PhD, FRCPC, FACE (2024)
S. Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE(2022-2023)
Felice A. Caldarella, MD, MBA, FACP, CDCES, FACE(2021-2022)
Howard M. Lando, MD, FACP, FACE(2020-2021)
Sandra L. Weber, MD, FACP, MACE (2019-2020)
Daniel L. Hurley, MD, MACE(2018-2019)
Jonathan D. Leffert, MD, FACP, FACE, ECNU (2017-2018)
R. Mack Harrell, MD, FACP, MACE, ECNU(…
moreAACE members,
Thank you to those that were able to join our virtual annual business meeting this past Friday. Many of you know how challenging it was to find an alternative to our normal in-person and we sincerely thank each of the more than 200 members that joined us online for your passion and enthusiasm for AACE.
The meeting included reports on elections, membership, and finances, followed by the Secretary’s report on proposed bylaws amendments. The report included 11 proposed bylaws amendments. Due to time constraints we were only able to address two of those amendments and take a…
morePeople with commercial insurance and the uninsured can access the copay card by calling the Lilly Diabetes Solution Center at (833) 808-1234
Eli Lilly and Company (NYSE: LLY), which introduced the Lilly Insulin Value Program $35 copay card in April 2020 to help people struggling financially during the COVID-19 crisis, today announced the program has been added to the company's comprehensive suite of insulin affordability solutions. Anyone with commercial insurance, and those without insurance at all, can continue filling their monthly prescription of…
moreRecognizing extraordinary accomplishments and exceptional contributions in the field of endocrinology, our annual awards are coveted, respected and sought-after throughout the endocrine medical world. The awards recognize nominees in areas of clinical excellence, education and research, public health, medical ethics, technological innovations, medical advancements, community involvement and others.
Click here to view the 2020 recipients.
Before you nominate, please review the …
more
